Exencial Wealth Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$436K Buy
8,334
+233
+3% +$11.9K 0.01% 428
2025
Q4
$415K Buy
8,101
+248
+3% +$11.5K 0.01% 429
2025
Q3
$305K Buy
7,853
+118
+2% +$4.06K 0.01% 451
2025
Q2
$233K Sell
7,735
-1,868
-19% -$53.4K 0.01% 465
2025
Q1
$274K Sell
9,603
-335
-3% -$10.6K 0.01% 435
2024
Q4
$328K Buy
9,938
+134
+1% +$5.06K 0.01% 420
2024
Q3
$366K Sell
9,804
-487
-5% -$17.8K 0.01% 412
2024
Q2
$346K Sell
10,291
-674
-6% -$22.6K 0.01% 412
2024
Q1
$392K Sell
10,965
-1,103
-9% -$38.2K 0.01% 397
2023
Q4
$398K Sell
12,068
-197
-2% -$5.29K 0.02% 379
2023
Q3
$334K Buy
12,265
+79
+0.6% +$2.38K 0.02% 349
2023
Q2
$384K Sell
12,186
-630
-5% -$19.6K 0.02% 333
2023
Q1
$348K Sell
12,816
-1,238
-9% -$37.4K 0.02% 331
2022
Q4
$427K Buy
14,054
+103
+0.7% +$3.1K 0.02% 310
2022
Q3
$420K Sell
13,951
-488
-3% -$15.4K 0.03% 297
2022
Q2
$400K Buy
14,439
+226
+2% +$6.45K 0.02% 300
2022
Q1
$478K Buy
14,213
+3,290
+30% +$114K 0.02% 293
2021
Q4
$461K Buy
+10,923
New +$487K 0.02% 327
2021
Q3
Sell
-8,752
Closed -$428K 429
2021
Q2
$428K Buy
8,752
+2,287
+35% +$110K 0.02% 336
2021
Q1
$325K Buy
6,465
+237
+4% +$13.1K 0.02% 344
2020
Q4
$319K Sell
6,228
-7,671
-55% -$365K 0.02% 302
2020
Q3
$572K Buy
13,899
+6,835
+97% +$282K 0.03% 244
2020
Q2
$295K Buy
+7,064
New +$279K 0.03% 270

Other funds holding SBIO